🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07633522
Starting soon Not applicable

Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid Tension-Type Headache

NCT07633522 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Hospital of Traditional Chinese Medicine
Phase
Not applicable
Started
2026-08
Last updated
2026-06-08

Condition(s) studied

Chronic MigraineTension-type Headache

Investigational drug(s) / intervention(s)

filiform needlingfire needling combined with filiform needling

filiform needling: Selection of acupoints for filiform needle therapy is integrated with the international standard acupuncture preventive treatment protocol for migraine specified in Acupuncture Clinical Practice Guidelines for Migraine issued by the World Federation of Acupuncture-Moxibustion Societies (WFAS 007.8-2023).Treatment was administered twice weekly for 8 weeks. Main Acupoints: Baihui (GV20), Shenting (GV24), Fengchi (GB20, bilateral), Benshen (GB13, bilateral), Shuaigu (GB8, bilateral), Taiyang (EX-HN5, bilateral). Adjunct Acupoints: For shaoyang headache: add Toulinqi (GB15), Yangbai (GB14), Fubai (GB10), Zulinqi (GB41), Waiguan (SJ5), Yanglingquan (GB34); For yangming headache: add Touwei (ST8), Hegu (LI4), Neiting (ST44); For taiyang headache: add Kunlun (BL60), Houxi (SI3); For jueyin headache: add Taichong (LR3), Qiuxu (GB40).

fire needling combined with filiform needling: Fire needling was used to puncture pericranial muscle tenderness areas (including the external occipital protuberance, superior nuchal line, nuchal plane, mastoid process; cervicoscapular areas; epicranial aponeurosis - frontal and temporal regions; upper trapezius, sternocleidomastoid, levator scapulae, temporalis, masseter, and occipitofrontalis muscles) in addition to filiform needling at meridian acupoints (same acupoints as the filiform needling group). Treatment was administered twice weekly for 8 weeks.

Study summary

The investigators conducted a multicenter, prospective, randomized controlled clinical study to learn whether fire needling combined with filiform needling applied to pericranial muscle tenderness areas can effectively treat chronic migraine with comorbid tension-type headache. The study will also evaluate the safety and long-term efficacy of this therapy. Its main target questions include:

1. Can fire needling significantly reduce the number of headache days per month?
2. What is the effect of this therapy on headache intensity, emotional symptoms, and quality of life? The investigators will compare "fire needling at pericranial tender points plus conventional filiform needling" versus "conventional filiform needling alone" to verify whether the key technique of fire needling plus conventional filiform needling provides unique additive value.

Participants will:

1. Receive treatment twice per week for 8 weeks (either in the experimental group or the control group),attend a follow-up visit at week 24 after enrollment
2. Keep a headache diary (recording headache frequency, pain intensity, duration, associated symptoms, etc.)
3. Regularly complete assessments of emotional status, quality of life, and number of pericranial tender points

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Meets the diagnostic criteria for tension-type headaches with pericranial tenderness; * Meets the diagnostic criteria for chronic migraine; * 18 years ≤ age ≤ 65 years; * Has sufficient understanding to complete the necessary examinations and tests for the study; * Voluntarily joins this study and signs the informed consent form. Exclusion Criteria: * Patients complicated with cluster headache or other primary headaches; * Patients with secondary headaches caused by intracranial space-occupying lesions, cranial infections, etc.; * Patients complicated with severe heart, liver or kidney impairment, coagulation disorders, infections, severe immunocompromise, or allergic predisposition; * Patients with alcohol or drug dependence; * Patients who are unable to cooperate with acupuncture treatment; * Women who are planning pregnancy, pregnant or breastfeeding; * Patients who have received acupuncture treatment within 3 months prior to enrollment.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Beijing Hospital of Traditional Chinese Medicine Beijing Beijing Municipality
Beijing Tiantan Hospital, Capital Medical University Beijing Beijing Municipality
Capital Medical University Affiliated Beijing Tongren Hospital Beijing Beijing Municipality

More Beijing Hospital of Traditional Chinese Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07633522 on ClinicalTrials.gov ↗ ← All trials in China